《美国股市》道指跌200点或0.7% 苹果逆升3%
美股个别发展。报道指苹果计划生产车辆及电池刺激股价造好,推升纳指。道指及标普500指数则因消费者信心数据及房屋销售数据欠佳而下跌。道指低开16点後反覆向下,尾市曾跌223点见29,992点,收市守在30,000点之上。
道琼斯工业平均指数跌200.94点或0.7%,收报30,015.51点。
标准普尔500指数跌7.66点或0.2%,收报3,687.26点。
纳斯达克指数升65.4点或0.5%,收报12,807.92点。
苹果升2.9%,为升幅最大道指成分股。软件股Salesforce升2.1%。连锁药房Walgreens跌3.4%,为跌幅最大道指成分股。药厂安进跌2.8%,高盛跌2.7%,雪佛龙及卡特彼勒各跌2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.